公开(公告)号：USD590247S1

公开(公告)日：2009-04-14

申请号：US29251793

申请日：2006-01-12

Applicant: Joshua Pokempner ,  Jonathan Wright ,  Kellie Hebert

Designer： Joshua Pokempner ,  Jonathan Wright ,  Kellie Hebert

公开(公告)号：US20060287344A1

公开(公告)日：2006-12-21

申请号：US11332617

申请日：2006-01-12

Applicant: Ronald Albers ,  Leticia Ayala ,  Steven Clareen ,  Maria Delgado Mederos ,  Robert Hilgraf ,  Sayee Hegde ,  Kevin Hughes ,  Adam Kois ,  Veronique Plantevin-Krenitsky ,  Meg McCarrick ,  Lisa Nadolny ,  Moorthy Palanki ,  Kiran Sahasrabudhe ,  John Sapienza ,  Yoshitaka Satoh ,  Marianne Sloss ,  Elise Sudbeck ,  Jonathan Wright

Inventor： Ronald Albers ,  Leticia Ayala ,  Steven Clareen ,  Maria Delgado Mederos ,  Robert Hilgraf ,  Sayee Hegde ,  Kevin Hughes ,  Adam Kois ,  Veronique Plantevin-Krenitsky ,  Meg McCarrick ,  Lisa Nadolny ,  Moorthy Palanki ,  Kiran Sahasrabudhe ,  John Sapienza ,  Yoshitaka Satoh ,  Marianne Sloss ,  Elise Sudbeck ,  Jonathan Wright

IPC: A61K31/52 ,  C07D473/14

CPC classification number: C07D473/00 ,  A61K31/52 ,  C07D473/32

Abstract: Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.

Abstract translation: 本文提供具有以下结构的氨基嘌呤化合物：其中R 1，R 2和R 3如本文所定义，组合物包含有效的 氨基嘌呤化合物的量和治疗或预防癌症，心血管疾病，肾脏疾病，自身免疫病症，炎性病症，黄斑变性，缺血再灌注损伤，疼痛及相关综合征，疾病相关性消耗，石棉 - 相关病症，肺动脉高压或通过抑制JNK途径可治疗或可预防的病症，包括向有需要的患者施用有效量的氨基嘌呤化合物。

公开(公告)号：US20060135878A1

公开(公告)日：2006-06-22

申请号：US11339908

申请日：2006-01-25

Applicant: Jonathan Wright ,  Anthony Ujhazy ,  Alison Hansford

Inventor： Jonathan Wright ,  Anthony Ujhazy ,  Alison Hansford

IPC: A61B5/08 ,  A61M16/00

CPC classification number: A61B5/4818 ,  A61B5/0402 ,  A61B5/0476 ,  A61B5/087 ,  A61B5/1135 ,  A61B5/1455 ,  A61M16/0066 ,  A61M16/0069 ,  A61M16/024 ,  A61M16/085 ,  A61M2016/0021 ,  A61M2230/205 ,  A61M2230/63 ,  G06F19/00

Abstract: Methods and apparatus for assessing the condition of and treating patients for stroke during the delivery of continuous positive airway pressure (CPAP) are disclosed. By determining central and obstructive apnea occurrences or the percentile of pressure delivered to the patient from patient airflow, stroke indicators may be calculated and analyzed to provide information on the type of stroke a patient has suffered and the degree of a patient's neuro-recovery. The apparatus may be programmed with a particular protocol intended to identify between alternative forms of CPAP treatment appropriate for the patient based upon an assessment of the patient's condition. The device can select and recommend between the various treatment forms, identify billing reimbursement codes and generate data to track patient response to stroke treatments.

公开(公告)号：US20060084877A1

公开(公告)日：2006-04-20

申请号：US11165705

申请日：2005-06-24

Applicant: Anthony Ujhazy ,  Jonathan Wright ,  Glenn Richards ,  David Bassin ,  Michael Berthon-Jones

Inventor： Anthony Ujhazy ,  Jonathan Wright ,  Glenn Richards ,  David Bassin ,  Michael Berthon-Jones

IPC: A61B5/02 ,  A61B5/08 ,  A61M16/00

CPC classification number: A61B5/4836 ,  A61B5/0826 ,  A61B5/087 ,  A61B5/7282 ,  A61B5/746 ,  A61M16/0051 ,  A61M16/0057 ,  A61M16/0066 ,  A61M16/0069 ,  A61M16/024 ,  A61M16/06 ,  A61M2016/0021 ,  A61M2016/0036 ,  A61M2205/3344 ,  A61M2230/005 ,  A61M2230/04 ,  A61M2230/10 ,  A61M2230/18 ,  A61M2230/40 ,  A61M2230/435 ,  A61M2230/63

Abstract: Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Airflow of the patient is measured to determine occurrences of central apneas. A heart failure index is calculated from a count of the number of central apneas that have occurred. The present heart failure index can be compared with a previously calculated heart failure index to determine how the patient's heart failure disease has changed and how it should be treated.

Abstract translation: 公开了通过递送持续气道正压通气来评估患者心力衰竭状况和治疗方法和装置。 测量患者的气流以确定中枢性呼吸暂停的发生。 从发生的中枢性呼吸暂停的次数计算心力衰竭指数。 可以将目前的心力衰竭指数与以前计算的心力衰竭指数进行比较，以确定患者的心力衰竭疾病如何改变以及如何治疗。

公开(公告)号：US6142866A

公开(公告)日：2000-11-07

申请号：US271940

申请日：1999-03-18

Applicant: Jonathan Wright

Inventor： Jonathan Wright

IPC: H05K7/20

CPC classification number: H05K7/20572 ,  H05K7/20209 ,  H05K7/207

Abstract: An air circulation control apparatus and method for a system such as a Base Transmission (or Transceiver) System (BTS) provides a control of an ambient air flow between inside and outside of the system. The apparatus includes at least one controller, such as a fan, and a member along an air flow path of the system. The member may be moveably mounted on the inside wall of the system. The controller operates in a forcing mode or a drawing mode to open or close the member so as to allow or not allow the air flow between inside and outside of the system.

Abstract translation: 用于诸如基地传输（或收发器）系统（BTS）的系统的空气循环控制装置和方法提供对系统内部和外部之间的环境空气流的控制。 该装置包括至少一个控制器，例如风扇，以及沿着系统的空气流动路径的构件。 构件可以可移动地安装在系统的内壁上。 控制器以强制模式或绘图模式操作以打开或关闭构件，以允许或不允许系统内部和外部之间的空气流动。

公开(公告)号：US5395835A

公开(公告)日：1995-03-07

申请号：US217395

申请日：1994-03-24

Applicant: Shelly A. Glase ,  Suzanne R. Kesten ,  Lawrence D. Wise ,  Jonathan Wright

Inventor： Shelly A. Glase ,  Suzanne R. Kesten ,  Lawrence D. Wise ,  Jonathan Wright

IPC: C07D295/12 ,  A61K31/44 ,  A61K31/4402 ,  A61K31/47 ,  A61K31/495 ,  A61K31/496 ,  A61P25/18 ,  A61P25/24 ,  A61P25/30 ,  A61P43/00 ,  C07D213/38 ,  C07D215/38 ,  C07D263/58 ,  C07D275/04 ,  C07D275/06 ,  C07D277/82 ,  C07D295/13 ,  C07D307/79 ,  C07D333/66 ,  C07D401/04 ,  C07D405/04 ,  C07D409/04 ,  A61K31/50 ,  C07D401/00 ,  C07D413/00

CPC classification number: C07D275/06 ,  C07D213/38 ,  C07D295/13 ,  C07D307/79 ,  C07D333/66

Abstract: Naphthalamides are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and as agents for the treatment of disorders which respond to dopaminergic blockade including psychotic depression, substance abuse, and compulsive disorders.

Abstract translation: 描述萘二甲酰胺以及其制备方法及其药物组合物，其可用作中枢神经系统试剂，并且特别可用作抗精神病药物和作为治疗对多巴胺能阻断作用的病症的药物，包括精神抑郁症，物质 虐待和强迫症。